IL17A and systemic lupus erythematosus: Decreased levels of serum complement are related to the presence of activated immune complexes in SLE, followed by the increased production of interferon (IFN) alpha and further proinflammatory cytokines, such as interleukin-17 (IL-17), IL-6, IL-2, IL-21, etc. [6,7].